We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

0001564590-19-005323 Sample Contracts

Standard Contracts

EXECUTIVE EMPLOYMENT AGREEMENT
Executive Employment Agreement • February 28th, 2019 • UroGen Pharma Ltd. • Pharmaceutical preparations • New York

This Executive Employment Agreement (the “Agreement”), is hereby made this 3rd day of January, 2019, between UroGen Pharma, Inc., a wholly owned subsidiary (the “Subsidiary”) of UroGen Pharma, Ltd. (the “Parent”, and the Subsidiary and the Parent together, the “Company”), and Elizabeth Barrett (the “Executive”) (collectively, the “Parties”).

EXECUTIVE EMPLOYMENT AGREEMENT
Executive Employment Agreement • February 28th, 2019 • UroGen Pharma Ltd. • Pharmaceutical preparations • New York

This Executive Employment Agreement (the “Agreement”), is hereby made this 5th day of December, 2017, by and among UroGen Pharma, Inc., (the “Company”, a wholly-owned subsidiary of UroGen Pharma, Ltd., the “Parent”), the Parent, and Mark P. Schoenberg, MD (the “Executive”) (collectively, the “Parties”).

EXECUTIVE EMPLOYMENT AGREEMENT
Executive Employment Agreement • February 28th, 2019 • UroGen Pharma Ltd. • Pharmaceutical preparations • California

This Executive Employment Agreement (the “Agreement”), is hereby made this 17th day of January between UroGen Pharma, Inc., (the “Company”, a wholly-owned subsidiary of UroGen Pharma, Ltd., the "Parent") and Stephen L. Mullennix (the “Executive”, or “you”) (collectively, the “Parties”).

SEPARATION AND RELEASE AGREEMENT
Separation and Release Agreement • February 28th, 2019 • UroGen Pharma Ltd. • Pharmaceutical preparations • Nevada

This Separation and Release Agreement (the “Agreement”) is made and entered into by and between UroGen Pharma Ltd. (“Company”) of the first part and Gary S. Titus (“Titus”) of the second part.

SEPARATION AND RELEASE AGREEMENT
Separation and Release Agreement • February 28th, 2019 • UroGen Pharma Ltd. • Pharmaceutical preparations

This Separation and Release Agreement (the “Agreement”) is made and entered into effective as of January 3, 2019 by and between UroGen Pharma Ltd. (“Company”) of the first part and Ron Bentsur (“Bentsur”) of the second part.